What is NDC 70748-323?

70748-323 is the product NDC for Bumetanide, Bumetanide .25 mg/mL injection, listed with the FDA by Lupin Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Lupin Pharmaceuticals, Inc., NDC labeler code 70748. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bumetanide?

122 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Bumetanide NDC 70748-323 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70748-323Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70748-0323Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70748-323-10	7074803231070748032310	10 VIAL in 1 CARTON (70748-323-10) / 4 mL in 1 VIALMarketed from Nov 11, 2024
70748-323-11	7074803231170748032311	10 VIAL in 1 CARTON (70748-323-11) / 10 mL in 1 VIALMarketed from Nov 11, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bumetanide
Generic name (nonproprietary): bumetanide
Active ingredients: Bumetanide — .25 mg/mL
Dosage form: Injection
Route: Intramuscular, Intravenous
Labeler: Lupin Pharmaceuticals, Inc.NDC labeler code 70748
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217153
Marketing start: Nov 11, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Increased Diuresis at Loop of Henle (Physiologic effect)
Identifiers: Product ID 70748-323_39d376d9-2fab-40d3-8592-668c5083a0c9SPL ID 39d376d9-2fab-40d3-8592-668c5083a0c9SPL set ID 2c71a17e-ed76-4545-b23e-9f4997b13c2fRxCUI 282486, 1727569UNII 0Y2S3XUQ5HUPC 0370748323014, 0370748323021
Pharmacologic class: Loop Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470748032310 followed by a unit qualifier and the quantity

Package 70748-0323-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 26, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Bumetanide injection, USP is indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome. Almost equal diuretic response occurs after oral and parenteral administration of bumetanide. Therefore, if impaired gastrointestinal absorption is suspected or oral administration is not practical, bumetanide should be given by the intramuscular or intravenous route. Successful treatment with bumetanide injection, USP following instances of allergic reactions to furosemide suggests a lack of cross-sensitivity.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70748-323

What is NDC 70748-323?: 70748-323 is the product NDC for Bumetanide, Bumetanide .25 mg/mL injection, listed with the FDA by Lupin Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bumetanide.
What is the active ingredient?: Bumetanide.
Who is the labeler?: Lupin Pharmaceuticals, Inc., NDC labeler code 70748. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bumetanide?: 122 other product NDCs are listed under this name. See all Bumetanide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Bumetanide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Bumetanide	Bumetanide .5 mg/1	TabletOral	Sandoz Inc	0781-8099	00781-8099-0100781-8099-05
Bumetanide	Bumetanide 1 mg/1	TabletOral	Sandoz Inc	0781-8113	00781-8113-0100781-8113-05
Bumetanide	Bumetanide 2 mg/1	TabletOral	Sandoz Inc	0781-8160	00781-8160-01
Bumetanide	Bumetanide .25 mg/mL	Injection, SolutionIntramuscular, Intravenous	Civica, Inc.	72572-210	72572-0210-10
Bumetanide	Bumetanide .25 mg/mL	Injection, SolutionIntramuscular, Intravenous	Civica, Inc.	72572-211	72572-0211-10
Bumetanide	Bumetanide .25 mg/mL	InjectionIntramuscular, Intravenous	Cardinal Health 107, LLC	55154-5131	55154-5131-05
Bumetanide	Bumetanide 1 mg/1	TabletOral	NorthStar Rx LLC	72603-900	72603-0900-0172603-0900-02
Bumetanide	Bumetanide .5 mg/1	TabletOral	NorthStar Rx LLC	72603-889	72603-0889-01
Bumetanide	Bumetanide 2 mg/1	TabletOral	NorthStar Rx LLC	72603-901	72603-0901-0172603-0901-02
Bumetanide	Bumetanide .25 mg/mL	Injection, SolutionIntramuscular, Intravenous	Anthea Pharma Private Limited	83854-007	83854-0007-10

All 123 Bumetanide NDCs